Skip to content

Bram odb: what changed

BE 0721.757.501NACE 86.951, PhysiotherapyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€48,289
2024 · €34,955+€13,335
Equity
€18,550
2024 · €18,550
Cash
€31,835
2024 · €53,618-€21,783
Balance sheet total
€69,942
2024 · €54,329+€15,612

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€37,343

    up €37,343 (+5,249%), from €711 to €38,055

    of which Furniture and vehicles: +€32,032

  • Cash -€21,783

    down €21,783 (-40.6%), from €53,618 to €31,835

    mainly Contributions, distributions and other (-€48,289) and Investment in fixed assets (net) (-€44,717)

Equity and liabilities
  • Other debts +€13,233

    up €13,233 (+37.7%), from €35,056 to €48,289

  • Tax, wage and social debts +€1,842

    up €1,842 (+300%), from €615 to €2,457

Income statement
  • Gross operating margin +€21,010

    up €21,010 (+41.1%), from €51,120 to €72,130

  • Depreciation +€3,654

    up €3,654 (+98.2%), from €3,720 to €7,374

  • Taxes +€1,977

    up €1,977 (+15.4%), from €12,865 to €14,842

  • Financial income -€1,581

    down €1,581 (-100%), from €1,581 to €0

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result.

Result 2024 €34,955
Gross operating margin +€21,010
Depreciation -€3,654
Other operating charges -€467
Financial income -€1,581
Financial charges +€4
Taxes -€1,977
Result 2025 €48,289
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€71,224
Investment -€44,717
Financing -€48,289
Cash 2024 €53,618
Net result for the year +€48,289
Depreciation +€7,374
Deferred charges and accrued income -€52
Trade debts +€538
Tax, wage and social debts +€1,842
Other debts +€13,233
Investment in fixed assets (net) -€44,717
Contributions, distributions and other -€48,289
Cash 2025 €31,835
brings cash intakes cash out
Every line side by side 35 lines
Line Code 2024 2025 Change %
Total assets 20/58 €54,329 €69,942 +€15,612 +28.7%
Fixed assets 21/28 €711 €38,055 +€37,343 +5,249%
Tangible fixed assets 22/27 €711 €38,055 +€37,343 +5,249%
Plant, machinery and equipment 23 - €5,311 +€5,311
Furniture and vehicles 24 €711 €32,743 +€32,032 +4,502%
Current assets 29/58 €53,618 €31,887 -€21,731 -40.5%
Amounts receivable within one year 40/41 €0 - =
Trade receivables 40 €0 - =
Cash at bank and in hand 54/58 €53,618 €31,835 -€21,783 -40.6%
Deferred charges and accrued income 490/1 - €52 +€52
Total equity and liabilities 10/49 €54,329 €69,942 +€15,612 +28.7%
Equity 10/15 €18,550 €18,550 = 0.0%
Contributions 10/11 €18,550 €18,550 = 0.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €35,779 €51,392 +€15,612 +43.6%
Amounts payable within one year 42/48 €35,779 €51,392 +€15,612 +43.6%
Current portion of amounts payable after more than one year 42 €0 - =
Trade debts 44 €108 €646 +€538 +497%
Suppliers 440/4 €108 €646 +€538 +497%
Taxes, remuneration and social security 45 €615 €2,457 +€1,842 +300%
Taxes 450/3 €615 €2,457 +€1,842 +300%
Other amounts payable 47/48 €35,056 €48,289 +€13,233 +37.7%
Non-recurring operating income 76A - €11,889 +€11,889
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €3,720 €7,374 +€3,654 +98.2%
Other operating charges 640/8 €1,057 €1,524 +€467 +44.2%
Gross operating margin 9900 €51,120 €72,130 +€21,010 +41.1%
Operating profit (loss) 9901 €46,344 €63,232 +€16,889 +36.4%
Financial income 75/76B €1,581 €0 -€1,581 -100%
Recurring financial income 75 €1,581 €0 -€1,581 -100%
Financial charges 65/66B €105 €101 -€4 -3.5%
Recurring financial charges 65 €105 €101 -€4 -3.5%
Profit (loss) for the period before taxes 9903 €47,820 €63,131 +€15,312 +32.0%
Income taxes 67/77 €12,865 €14,842 +€1,977 +15.4%
Profit (loss) for the period 9904 €34,955 €48,289 +€13,335 +38.1%
Profit (loss) for the period to be appropriated 9905 €34,955 €48,289 +€13,335 +38.1%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Value of the equity

Indication, not a valuation or advice
€126,886 to €173,930

Midpoint €146,488 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate. Change the assumptions and the value follows.

Adjusted equity €18,550
Capitalised earnings €235,221 to €329,310
Indication €126,886 to €173,930

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€18,550
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€18,550

Capitalised earnings

net result for the year (9904)
2025
€48,289
excluding non-recurring income and charges
€36,401
2024
€34,955
2023
€27,436
2022
€10,083
2021
€8,054
Average result, excluding non-recurring income and charges
€32,931
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€235,221 / €274,425 / €329,310

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 21 November 2026 via checked.be.